152 related articles for article (PubMed ID: 26207899)
1. Small Molecule Inhibitors of Plasminogen Activator Inhibitor-1 Elicit Anti-Tumorigenic and Anti-Angiogenic Activity.
Placencio VR; Ichimura A; Miyata T; DeClerck YA
PLoS One; 2015; 10(7):e0133786. PubMed ID: 26207899
[TBL] [Abstract][Full Text] [Related]
2. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.
Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T
Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strategy in ovarian cancer.
Mashiko S; Kitatani K; Toyoshima M; Ichimura A; Dan T; Usui T; Ishibashi M; Shigeta S; Nagase S; Miyata T; Yaegashi N
Cancer Biol Ther; 2015; 16(2):253-60. PubMed ID: 25587663
[TBL] [Abstract][Full Text] [Related]
4. XR5967, a novel modulator of plasminogen activator inhibitor-1 activity, suppresses tumor cell invasion and angiogenesis in vitro.
Brooks TD; Wang SW; Brünner N; Charlton PA
Anticancer Drugs; 2004 Jan; 15(1):37-44. PubMed ID: 15090742
[TBL] [Abstract][Full Text] [Related]
5. Novel Plasminogen Activator Inhibitor-1 Inhibitors Prevent Diabetic Kidney Injury in a Mouse Model.
Jeong BY; Uddin MJ; Park JH; Lee JH; Lee HB; Miyata T; Ha H
PLoS One; 2016; 11(6):e0157012. PubMed ID: 27258009
[TBL] [Abstract][Full Text] [Related]
6. A small molecule inhibitor to plasminogen activator inhibitor 1 inhibits macrophage migration.
Ichimura A; Matsumoto S; Suzuki S; Dan T; Yamaki S; Sato Y; Kiyomoto H; Ishii N; Okada K; Matsuo O; Hou FF; Vaughan DE; van Ypersele de Strihou C; Miyata T
Arterioscler Thromb Vasc Biol; 2013 May; 33(5):935-42. PubMed ID: 23471233
[TBL] [Abstract][Full Text] [Related]
7. PAI-1 is a critical regulator of FGF23 homeostasis.
Eren M; Place AT; Thomas PM; Flevaris P; Miyata T; Vaughan DE
Sci Adv; 2017 Sep; 3(9):e1603259. PubMed ID: 28924605
[TBL] [Abstract][Full Text] [Related]
8. PAI-1 contributes to homocysteine-induced cellular senescence.
Sun T; Ghosh AK; Eren M; Miyata T; Vaughan DE
Cell Signal; 2019 Dec; 64():109394. PubMed ID: 31472244
[TBL] [Abstract][Full Text] [Related]
9. A novel inhibitor of plasminogen activator inhibitor-1 provides antithrombotic benefits devoid of bleeding effect in nonhuman primates.
Izuhara Y; Yamaoka N; Kodama H; Dan T; Takizawa S; Hirayama N; Meguro K; van Ypersele de Strihou C; Miyata T
J Cereb Blood Flow Metab; 2010 May; 30(5):904-12. PubMed ID: 20087372
[TBL] [Abstract][Full Text] [Related]
10. A Small Molecule Inhibitor of Plasminogen Activator Inhibitor-1 Reduces Brain Amyloid-β Load and Improves Memory in an Animal Model of Alzheimer's Disease.
Akhter H; Huang WT; van Groen T; Kuo HC; Miyata T; Liu RM
J Alzheimers Dis; 2018; 64(2):447-457. PubMed ID: 29914038
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of PAI (Plasminogen Activator Inhibitor)-1 Improves Brain Collateral Perfusion and Injury After Acute Ischemic Stroke in Aged Hypertensive Rats.
Chan SL; Bishop N; Li Z; Cipolla MJ
Stroke; 2018 Aug; 49(8):1969-1976. PubMed ID: 29991657
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen Activator Inhibitor-1 in Cancer: Rationale and Insight for Future Therapeutic Testing.
Placencio VR; DeClerck YA
Cancer Res; 2015 Aug; 75(15):2969-74. PubMed ID: 26180080
[TBL] [Abstract][Full Text] [Related]
13. A small molecule inhibitor of PAI-1 protects against doxorubicin-induced cellular senescence.
Ghosh AK; Rai R; Park KE; Eren M; Miyata T; Wilsbacher LD; Vaughan DE
Oncotarget; 2016 Nov; 7(45):72443-72457. PubMed ID: 27736799
[TBL] [Abstract][Full Text] [Related]
14. Targeting plasminogen activator inhibitor-1 inhibits angiogenesis and tumor growth in a human cancer xenograft model.
Gomes-Giacoia E; Miyake M; Goodison S; Rosser CJ
Mol Cancer Ther; 2013 Dec; 12(12):2697-708. PubMed ID: 24072883
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator inhibitor-1 regulates macrophage-dependent postoperative adhesion by enhancing EGF-HER1 signaling in mice.
Honjo K; Munakata S; Tashiro Y; Salama Y; Shimazu H; Eiamboonsert S; Dhahri D; Ichimura A; Dan T; Miyata T; Takeda K; Sakamoto K; Hattori K; Heissig B
FASEB J; 2017 Jun; 31(6):2625-2637. PubMed ID: 28270519
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of orally bioavailable farnesyltransferase inhibitor, ABT-100, is mediated by antiproliferative, proapoptotic, and antiangiogenic effects in xenograft models.
Ferguson D; Rodriguez LE; Palma JP; Refici M; Jarvis K; O'Connor J; Sullivan GM; Frost D; Marsh K; Bauch J; Zhang H; Lin NH; Rosenberg S; Sham HL; Joseph IB
Clin Cancer Res; 2005 Apr; 11(8):3045-54. PubMed ID: 15837760
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis.
Kwaan HC; Wang J; Svoboda K; Declerck PJ
Br J Cancer; 2000 May; 82(10):1702-8. PubMed ID: 10817507
[TBL] [Abstract][Full Text] [Related]
18. Intracellular Expression of PAI-1 Specific Aptamers Alters Breast Cancer Cell Migration, Invasion and Angiogenesis.
Fortenberry YM; Brandal SM; Carpentier G; Hemani M; Pathak AP
PLoS One; 2016; 11(10):e0164288. PubMed ID: 27755560
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation.
Ji Y; Weng Z; Fish P; Goyal N; Luo M; Myears SP; Strawn TL; Chandrasekar B; Wu J; Fay WP
Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2167-2175. PubMed ID: 27659097
[TBL] [Abstract][Full Text] [Related]
20. Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents.
Eilon GF; Gu J; Slater LM; Hara K; Jacobs JW
Cancer Chemother Pharmacol; 2000; 45(3):183-91. PubMed ID: 10663635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
